H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 8, 2013, Pages 3005-3010

  Sahaf, Bita ^a   Yang, Yang ^a   Arai, Sally ^a   Herzenberg, Leonard A ^a   Herzenberg, Leonore A ^a   Miklos, David B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allogeneic; Antigen specific B cells; DDX3Y; Transplantation

Indexed keywords

ALLOANTIGEN; B LYMPHOCYTE RECEPTOR; DEAD BOX PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN RECEPTOR;

ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIGEN BINDING; ANTIGEN BINDING CELL; ARTICLE; B LYMPHOCYTE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC CELL; HUMAN; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AMINO ACID SEQUENCE; B-LYMPHOCYTES; CELL SEPARATION; CHRONIC DISEASE; FEMALE; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; H-Y ANTIGEN; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84874243928     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1222900110     Document Type: Article

References (28)

1. Socié G (2011) Chronic GVHD: A new risk score? Blood 117 (24):6408-6409.
2. Socié G, et al.; ATG-Fresenius Trial Group (2011) Chronic graft-versus-host disease: Long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius. Blood 117 (23):6375-6382.
3. Kohrt HE, et al. (2009) TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. Blood 114 (5):1099-1109.
4. Arai S, et al. (2012) Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence. Blood 119 (25):6145-6154.
5. Allen JL, et al. (2012) B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways. Blood 120 (12):2529-2536.
6. Kuzmina Z, et al. (2011) Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia. Blood 117 (7):2265-2274.
7. Sarantopoulos S, et al. (2007) High levels of B-cell activating factor in patients with active chronic graft-versus-host disease. Clin Cancer Res 13 (20):6107-6114.
8. Sarantopoulos S, et al. (2011) Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease. Blood 117 (7):2275-2283.
9. She K, et al. (2007) Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease. Biol Blood Marrow Transplant 13 (4):386-397.
10. Sarantopoulos S, et al. (2009) Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. Blood 113 (16):3865-3874.
11. Miklos DB, et al. (2004) Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood 103 (1):353-359.
12. Wechalekar A, Cranfield T, Sinclair D, Ganzckowski M (2005) Occurrence of auto-antibodies in chronic graft vs. host disease after allogeneic stem cell transplantation. Clin Lab Haematol 27 (4):247-249.
13. Schultz KR, et al. (2006) Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report. Biol Blood Marrow Transplant 12 (2):126-137.
14. Socié G (2011) Chronic GVHD: B cells come of age. Blood 117 (7):2086-2087.
15. Deneberg S, Lerner R, Ljungman P, Ringden O, Hägglund H (2007) Relapse of preB-ALL after rituximab treatment for chronic graft versus host disease: implications for its use? Med Oncol 24 (3):354-356.
16. Kharfan-Dabaja MA, Bazarbachi A (2010) Emerging role of CD20 blockade in allo-geneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 16 (10):1347-1354.
17. Kharfan-Dabaja MA, et al. (2009) Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: A systematic review and meta-analysis. Biol Blood Marrow Transplant 15 (9):1005-1013.
18. Zaja F, et al.; GITMO (Gruppo Italiano Trapianto Midollo Osseo) (2007) Treatment of refractory chronic GVHD with rituximab: a GITMO study. Bone Marrow Transplant 40 (3):273-277.
19. Cutler C, et al. (2006) Rituximab for steroid-refractory chronic graft-versus-host disease. Blood 108 (2):756-762.
20. Miklos DB, et al. (2005) Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood 105 (7):2973-2978.
21. Yang Y, et al. (2012) Antigen-specific memory in B-1a and its relationship to natural immunity. Proc Natl Acad Sci USA 109 (14):5388-5393.
22. Yang Y, et al. (2012) Antigen-specific antibody responses in B-1a and their relationship to natural immunity. Proc Natl Acad Sci USA 109 (14):5382-5387.
23. Young JS, et al. (2012) Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4+ T cells that mediate autoimmune-like chronic graft-versus-host disease. J Immunol 189 (1):222-233.
24. Srinivasan M, et al. (2012) Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bron-chiolitis obliterans. Blood 119 (6):1570-1580.
25. Filipovich AH, et al. (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11 (12):945-956.
26. Millan MT, et al. (2002) Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 73 (9):1386-1391.
27. Sahaf B, et al. (2008) Culturing of human peripheral blood cells reveals unsuspected lymphocyte responses relevant to HIV disease. Proc Natl Acad Sci USA 105 (13):5111-5116.
28. Herzenberg LA, Tung J, Moore WA, Herzenberg LA, Parks DR (2006) Interpreting flow cytometry data: A guide for the perplexed. Nat Immunol 7 (7):681-685.